These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3124860)

  • 1. Folate status of rheumatoid arthritis patients receiving long-term, low-dose methotrexate therapy.
    Morgan SL; Baggott JE; Altz-Smith M
    Arthritis Rheum; 1987 Dec; 30(12):1348-56. PubMed ID: 3124860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
    van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
    Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement.
    Hornung N; Ellingsen T; Stengaard-Pedersen K; Poulsen JH
    J Rheumatol; 2004 Dec; 31(12):2374-81. PubMed ID: 15570637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients.
    Leeb BF; Witzmann G; Ogris E; Studnicka-Benke A; Andel I; Schweitzer H; Smolen JS
    Clin Exp Rheumatol; 1995; 13(4):459-63. PubMed ID: 7586777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis.
    Blits M; Jansen G; Assaraf YG; van de Wiel MA; Lems WF; Nurmohamed MT; van Schaardenburg D; Voskuyl AE; Wolbink GJ; Vosslamber S; Verweij CL
    Arthritis Rheum; 2013 Nov; 65(11):2791-802. PubMed ID: 23897011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.
    de Rotte MC; de Jong PH; Pluijm SM; Calasan MB; Barendregt PJ; van Zeben D; van der Lubbe PA; de Sonnaville PB; Lindemans J; Hazes JM; de Jonge R
    Arthritis Rheum; 2013 Nov; 65(11):2803-13. PubMed ID: 24166792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
    Morgan SL; Baggott JE; Lee JY; Alarcón GS
    J Rheumatol; 1998 Mar; 25(3):441-6. PubMed ID: 9517760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate supplementation in methotrexate-treated rheumatoid arthritis patients.
    Stewart KA; Mackenzie AH; Clough JD; Wilke WS
    Semin Arthritis Rheum; 1991 Apr; 20(5):332-8. PubMed ID: 2068578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folinate Supplementation Ameliorates Methotrexate Induced Mitochondrial Formate Depletion In Vitro and In Vivo.
    Sou NL; Huang YH; Chen DY; Chen YM; Tang FY; Ko HA; Fan YH; Lin YY; Wang YC; Chih HM; Shane B; Huang WN; Chiang EI
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates.
    Kremer JM; Galivan J; Streckfuss A; Kamen B
    Arthritis Rheum; 1986 Jul; 29(7):832-5. PubMed ID: 2427090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; James J; Frampton C; Barclay ML
    Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis.
    Morgan SL; Oster RA; Lee JY; Alarcón GS; Baggott JE
    Arthritis Rheum; 2004 Oct; 50(10):3104-11. PubMed ID: 15476202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate.
    Stamp LK; Chapman PT; O'Donnell JL; Zhang M; James J; Frampton C; Barclay ML; Kennedy MA; Roberts RL
    Pharmacogenet Genomics; 2010 Jun; 20(6):367-76. PubMed ID: 20386493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of inhibition of a catabolic pathway of methotrexate metabolism in its efficacy for rheumatoid arthritis.
    Morgan SL; Baggott JE
    Med Hypotheses; 2019 Jan; 122():10-15. PubMed ID: 30593388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Ghogomu ET; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    J Rheumatol; 2014 Jun; 41(6):1049-60. PubMed ID: 24737913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate therapy in rheumatoid arthritis patients diminishes lectin-induced mononuclear cell proliferation.
    Hine RJ; Everson MP; Hardin JM; Morgan SL; Alarcòn GS; Baggott JE; Koopman WJ; Krumdieck CL
    Rheumatol Int; 1990; 10(4):165-9. PubMed ID: 2259842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity.
    van Ede AE; Laan RF; Blom HJ; De Abreu RA; van de Putte LB
    Semin Arthritis Rheum; 1998 Apr; 27(5):277-92. PubMed ID: 9572710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
    Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate supplementation during methotrexate therapy for rheumatoid arthritis.
    Morgan SL; Baggott JE
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S102-9. PubMed ID: 21044441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.